You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Practice Guideline Insights: Vitamin D Deficiency Recommendations

  • Authors: News Author: Megan Brooks
    CME Author: Charles P. Vega, MD, FAAFP
  • CME/CE Released: 5/7/2013
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 5/7/2014
Start Activity


Target Audience and Goal Statement

This article is intended for primary care clinicians, endocrinologists, and other specialists who care for children or adults regarding recommended dietary intakes of vitamin D.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  1. Describe the current guideline's recommended dietary intakes of vitamin D among children.
  2. Describe the current guideline's recommended dietary intakes of vitamin D among older adults.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Megan Brooks

    Megan Brooks is a freelance writer for Medscape Medical News.

    Disclosures

    Disclosure: Megan Brooks has no relevant financial relationships to disclose.

Editor/Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.

CME Author(s)

  • Charles P. Vega, MD, FAAFP

    Associate Professor and Residency Director, Department of Family Medicine, University of California-Irvine, Irvine

    Disclosures

    Disclosure: Charles P. Vega, MD, FAAFP, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Joi Tisdale

    CME Program Manager, Medscape, LLC

    Disclosures

    Disclosure: Joi Tisdale has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This enduring material activity, Medscape Education Clinical Briefs has been reviewed and is acceptable for up to 260 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 1, 2012. Term of approval is for 1 year from this date. Each Clinical Brief is approved for .25 Prescribed credits. Credit may be claimed for 1 year from the date of each Clinical Brief. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Note: Total credit is subject to change based on topic selection and article length.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    AAFP Accreditation Questions

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number 0461-0000-13-017-H05-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME/CE

Practice Guideline Insights: Vitamin D Deficiency Recommendations

Authors: News Author: Megan Brooks CME Author: Charles P. Vega, MD, FAAFPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME/CE Released: 5/7/2013

Valid for credit through: 5/7/2014

processing....

Clinical Context

Vitamin D deficiency can result in problems in forming and maintaining bone, and all clinicians should be aware of the potential for vitamin D deficiency among their patients. The authors of the current guideline provide a review of sources of vitamin D. Most active vitamin D in humans is produced after exposure to sunlight. A mild sunburn is equivalent to consumption of 10,000 to 25,000 IU of dietary vitamin D, and some evidence exists that vitamin D produced in the skin may remain metabolically active longer than dietary vitamin D.

Sun exposure can also clearly be harmful, but multiple foods in western countries are fortified with vitamin D. In addition, fish and shiitake mushrooms are good sources of vitamin D.

Although little doubt remains about the importance of vitamin D, the recommended daily allowance of vitamin D has remained an issue of controversy. The Endocrine Society addresses this subject in its 2011 guidelines.

Study Synopsis and Perspective

On June 7, 2011, The Endocrine Society unveiled a Clinical Practice Guideline on the evaluation, treatment, and prevention of vitamin D deficiency, with an emphasis on the care of patients who are at risk for vitamin D deficiency.

Michael F. Holick, MD, PhD, from Boston University Medical Center, Massachusetts, who chaired the 8-member task force that developed the guideline, summarized the recommendations at a press briefing at ENDO 2011: The Endocrine Society 93rd Annual Meeting.

The guideline also was published online on June 6, 2011, in the Journal of Clinical Endocrinology & Metabolism.

"Based on all the evidence, at a minimum, we recommend vitamin D levels of 30 ng/mL, and because of the vagaries of some of the assays, to guarantee sufficiency, we recommend between 40 and 60 ng/mL for both children and adults," Dr. Holick said.

The society's clinical practice guideline was developed by "experts in the field who carefully reviewed the current literature and features the latest and most comprehensive recommendations available on the prevention and treatment of vitamin D deficiency," he said.

The guideline recommends that clinicians screen for vitamin D deficiency in people at risk for deficiency, including obese individuals, blacks, pregnant and lactating women, and patients with malabsorption syndromes.

"We do not recommend population screening for vitamin D deficiency in individuals who are not at risk," Dr. Holick said, but added that "vitamin D deficiency is very common in all age groups — essentially everyone is at risk."

Screening should be performed using a "reliable assay" for 25-hydroxyvitamin D (25[OH]D), not 1,25-dihydroxy-vitamin D (1,25[OH]2D), "which tells you nothing about vitamin D status," Dr. Holick said. Vitamin D deficiency is defined as 25(OH)D levels below 20 ng/mL.

"Considering that vitamin D deficiency is very common in all age groups and that few foods contain vitamin D, the task force recommended supplementation at suggested daily intake and tolerable upper limit levels, depending on age and clinical circumstances," the guideline states.

For bone health, infants and children up to 1 year of age require at least 400 IU/day vitamin D, and children 1 year and older need at least 600 IU/day, the guideline states. However, at least 1000 IU/day of vitamin D may be needed to raise the blood level of 25(OH)D consistently above 30 ng/mL, it notes.

Adults aged 19 to 70 years require at least 600 IU/day of vitamin D to maximize bone health and muscle function. However, getting 25(OH)D levels consistently above 30 ng/mL may require at least 1500 to 2000 IU/day of vitamin D.

Adults 70 years and older require at least 800 IU/day of vitamin D for bone health and fall prevention; at least 1500 to 2000 IU/day of supplemental vitamin D may be needed to keep 25(OH)D levels above 30 ng/mL.

Pregnant and lactating women need a minimum of 600 IU/day of vitamin D; 1500 IU/day may be needed to maintain blood levels of 25(OH)D higher than 30 ng/mL.

"Obese children and adults and children and adults on anticonvulsant medications, glucocorticoids, antifungals such as ketoconazole, and medications for AIDS need at least 2 to 3 times more vitamin D for their age group to satisfy their body's vitamin D requirement," Dr. Holick reported.

Tolerable upper limits of vitamin D, which "should not be exceeded without medical supervision," include the following:

  • 1000 IU/day for infants aged up to 6 months,
  • 1500 IU/day for infants aged 6 months to 1 year old,
  • 2500 IU/day for children aged 1 to 3 years,
  • 3000 IU/day for children aged 4 to 8 years, and
  • 4000 IU/day for everyone older than 8 years.

However, the guideline states that for individuals who are vitamin D deficient, higher levels of vitamin D (2000 IU/day for children up to age 1 year; 4000 IU/day for children aged 1 - 18 years, and up to 10,000 IU/day for adults aged 19 years and older) "may be necessary to correct, treat, and prevent vitamin D deficiency," Dr. Holick said.

"Both vitamin D2 and vitamin D3 is equally fine in treating and preventing vitamin D deficiency," he added.

For all age groups, it is unknown whether these age-specific levels of vitamin D are "enough to provide all of the potential nonskeletal health benefits associated with vitamin D," Dr. Holick noted.

He also said that at present, "there is not sufficient evidence to recommend prescribing vitamin D to attain the noncalcemic benefit for cardiovascular protection." However, association studies have suggested that increasing vitamin D levels may help protect against some cancers, including colorectal cancer, as well as infectious disease, diabetes, and high blood pressure.

The upper limits and the dietary intake levels in The Endocrine Society guideline for the most part mirror those of the 2010 Institute of Medicine consensus report, "Dietary Reference Intakes for Calcium and Vitamin D," although The Endocrine Society gives more explicit recommendations for care.

Dr. Holick commented that the Institute of Medicine report used a "population model, not a medical model, and was not intended to direct physicians on care of patients. It was up to professional associations to establish guidelines of care, which is why [The Endocrine Society] became involved."

Christine Stencel, media relations officer of the National Academy of Sciences, said the committee that issued the 2010 report is no longer an entity and would not have a comment on The Endocrine Society guideline.

"At some point down the road, there is the potential that [Institute of Medicine] could convene a new committee to reexamine all the new information and look at changing the [dietary reference intakes], but at this point we wouldn't do any immediate re-look at this," she said.

Development of the clinical practice guideline was supported solely by The Endocrine Society. Dr. Holick has disclosed financial or business/organizational interests with Merck, Novartis, Nichols-Quest Diagnostics, Bayer, Aventis, Warner Chilcott, Amgen, the UV Foundation, DMI, and the Mushroom Council. A complete list of disclosures for the task force is listed with the original article.

ENDO 2011: The Endocrine Society 93rd Annual Meeting. Presented June 6, 2011.

J Clin Endocrinol Metabol. Published online June 6, 2011. Abstract

Study Highlights

  • The guidelines were developed after examination of systematic reviews of vitamin D intake, and the authors also incorporated suggestions from members of The Endocrine Society after a draft document was posted on the society's Web page.
  • Screening for vitamin D deficiency should only be done in high-risk patients, including patients with known bone disease, kidney disease, cirrhosis, and malabsorption syndromes. The guidelines also classify African Americans and Hispanics as well as obese individuals as high-risk for vitamin D deficiency. Pregnant women may be screened for vitamin D deficiency.
  • Clinicians should use a 25(OH)D level to screen for vitamin D deficiency. A level of 20 ng/mL or less constitutes vitamin D deficiency.
  • Infants younger than 1 year should receive at least 400 IU/day of vitamin D, and older children and adolescents should receive at least 600 IU/day.
  • Adults between 19 and 65 years old should receive at least 600 IU/day of vitamin D. Adults 65 years and older should receive at least 800 IU/day.
  • These recommended values are designed to maximize bone health, and the guidelines also recommend vitamin D to help prevent falls among older adults. However, the authors found insufficient evidence to recommend the use of vitamin D supplements for other health-related goals, such as cardiovascular disease prevention or improvement in the quality of life.
  • Among special populations, pregnant women should receive at least 600 IU of vitamin D per day. Obese children and adults should receive vitamin D at least 2 to 3 times more than the recommended daily values for individuals at a normal weight.
  • Very high doses of vitamin D are associated with hypercalcemia and other complications. The maintenance dose of vitamin D should not exceed 2500 IU/day for children between 1 and 3 years old, 3000 IU/day for children between 4 and 8 years old, and 4000 IU/day among individuals older than 8 years.
  • However, treatment of vitamin D deficiency requires higher doses of vitamin D (2000 IU/day for 6 weeks among infants, children, and adolescents; 6000 IU/day for 8 weeks among adults). In general, the dose of vitamin D in the treatment of deficiency should be approximately 50,000 IU/week.
  • Either vitamin D2 or D3 may be used to treat vitamin D deficiency.
  • Maintenance therapy after treatment of vitamin D deficiency requires higher doses of vitamin D (1500 - 2000 IU/day among adults).

Clinical Implications

  • The current guidelines from The Endocrine Society recommend that at least 600 IU of vitamin D per day is necessary to maximize bone health among children and adolescents between 1 and 18 years old.
  • The current guidelines from The Endocrine Society recommend that at least 800 IU of vitamin D per day is necessary to maximize bone health and prevent falls among adults at 65 years and older.

CME Test

  • Print